↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

55 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 Busulfan, cyclophosphamide, antithymocyte globulin Busulfan 3件: D00248, D00287, D07760 💬 - - 2件: 19, 20 💬
2 Busulfan, cyclophosphamide, atg Busulfan 3件: D00248, D00287, D07760 💬 - - 1件: 19 💬
3 Busulfan, cyclophosphamide, atg, gcsf Busulfan 3件: D00248, D00287, D07760 💬 - - 2件: 65, 284 💬
4 Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen) Antithymocyte immunoglobulin (rabbit) 5件: D00248, D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 326 💬
5 Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine. Busulfan 6件: D00184, D00248, D00287, D01907, D07760, D07966 💬 6件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬 37件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 2件: 60, 285 💬
6 Campath, fludarabine, cyclophosphamide Cyclophosphamide 4件: D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 2件: 65, 284 💬
7 Cyclophosphamide Cyclophosphamide 2件: D00287, D07760 💬 - - 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
8 Cyclophosphamide (cy) Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 60 💬
9 Cyclophosphamide (cy) (plan 1) Cyclophosphamide 2件: D00287, D07760 💬 - - 2件: 60, 285 💬
10 Cyclophosphamide (cy) (plan 2) Cyclophosphamide 2件: D00287, D07760 💬 - - 2件: 60, 285 💬
11 Cyclophosphamide (cytoxan) Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 65 💬
12 Cyclophosphamide (drug) Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 13 💬
13 Cyclophosphamide + pred Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 283 💬
14 Cyclophosphamide 100mg Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 60 💬
15 Cyclophosphamide 150mg Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 60 💬
16 Cyclophosphamide 30 Cyclophosphamide 2件: D00287, D07760 💬 - - 3件: 65, 285, 326 💬
17 Cyclophosphamide 40 Cyclophosphamide 2件: D00287, D07760 💬 - - 3件: 65, 285, 326 💬
18 Cyclophosphamide 50mg Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 60 💬
19 Cyclophosphamide 50mg oral tablet Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 162 💬
20 Cyclophosphamide and atg Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 13 💬
21 Cyclophosphamide and fludarabine Cyclophosphamide 4件: D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 13 💬
22 Cyclophosphamide and steroids Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 222 💬
23 Cyclophosphamide dose level 1 Cyclophosphamide 2件: D00287, D07760 💬 - - 2件: 65, 284 💬
24 Cyclophosphamide dose level 2 Cyclophosphamide 2件: D00287, D07760 💬 - - 2件: 65, 284 💬
25 Cyclophosphamide dose level 3 Cyclophosphamide 2件: D00287, D07760 💬 - - 2件: 65, 284 💬
26 Cyclophosphamide dose level 4 Cyclophosphamide 2件: D00287, D07760 💬 - - 2件: 65, 284 💬
27 Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids Azathioprine 6件: D00142, D00238, D00287, D02115, D03033, D07760 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 1件: 44 💬
28 Cyclophosphamide injection 1g Cyclophosphamide 2件: D00287, D07760 💬 - - 3件: 50, 51, 52 💬
29 Cyclophosphamide monohydrate Cyclophosphamide 2件: D00287, D07760 💬 - - 4件: 13, 60, 96, 256 💬
30 Cyclophosphamide post transplant Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 65 💬
31 Cyclophosphamide(ctx) Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 224 💬
32 Cyclophosphamide, azathioprine,prednisone,methylprednisolone Azathioprine 11件: D00238, D00287, D00407, D00473, D00751, D00979, D03033, D05000, D05001, D05002, D07760 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 42, 43, 45 💬
33 Cyclophosphamide, bortezomib, and dexamethasone (cybord) Bortezomib 12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬 2件: NR3C1, PSMB5 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 28 💬
34 Cyclophosphamide, bortezomib, dexamethasone Bortezomib 12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬 2件: NR3C1, PSMB5 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 28 💬
35 Cyclophosphamide, bortezomib, dexamethasone plus daratumumab Bortezomib 13件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760, D10777 💬 3件: CD38, NR3C1, PSMB5 💬 16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 1件: 28 💬
36 Cyclophosphamide, fludarabine Cyclophosphamide 4件: D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 285 💬
37 Cyclophosphamide, fludarabine , thymoglobulin Antithymocyte immunoglobulin (rabbit) 4件: D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 60 💬
38 Cyclophosphamide, fludarabine, rabbit atg Antithymocyte immunoglobulin (rabbit) 4件: D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 60 💬
39 Cyclophosphamide, fludarabine, thymoglobulin Antithymocyte immunoglobulin (rabbit) 4件: D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 60 💬
40 Cyclophosphamide,campath ih and tbi Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 60 💬
41 Cyclophosphamide,cyclosporine a Cyclophosphamide 3件: D00184, D00287, D07760 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件: 60 💬
42 Cyclophosphamide-prednisone-azathioprine Azathioprine 5件: D00238, D00287, D00473, D03033, D07760 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 49 💬
43 Cyclophosphamide/glatiramer acetate Acetate 3件: D00287, D04318, D07760 💬 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
44 Fludarabine, cyclophosphamide Cyclophosphamide 4件: D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 60 💬
45 Haploidentical hsct using tbi free regimen, ''atg'' with ''post transplant cyclophosphamide'' Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 60 💬
46 High-dose cyclophosphamide Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 96 💬
47 Iv cyclophosphamide Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 51 💬
48 Lenalidomide, dexamethasone and cyclophosphamide Cyclophosphamide 12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687, D07760 💬 2件: NR3C1, TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 28 💬
49 Prednisone and cyclophosphamide Cyclophosphamide 3件: D00287, D00473, D07760 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 66 💬
50 Prednisone plus cyclophosphamide Cyclophosphamide 3件: D00287, D00473, D07760 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 66 💬
51 Prednisone, cyclophosphamide Cyclophosphamide 3件: D00287, D00473, D07760 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 40 💬
52 Prednisone, methylprednisolone,cyclophosphamides Methylprednisolone 7件: D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 42, 43, 45 💬
53 Procedure: cyclophosphamide Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 65 💬
54 Rituximab and cyclophosphamide iv Cyclophosphamide 3件: D00287, D02994, D07760 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 35 💬
55 Thalidomide, cyclophosphamide and prednisone Cyclophosphamide 4件: D00287, D00473, D00754, D07760 💬 2件: NR3C1, TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 331 💬

先頭へ